GrantForecasted — not yet open✓ Small businesses may apply
Investigate Novel Therapeutic Interventions and Testing Strategies for Neurological Disorders Including to Treat, Modify and Prevent the Development of Epilepsy (U24 Clinical Trial Not Allowed)
National Institutes of Health
Award ceiling
$4,000,000
Award floor
$3,500,000
Program funding
$6,200,000
- Opportunity #
- RFA-NS-26-002
- Agency
- National Institutes of Health
- ALN (CFDA)
- 93.853
- Status
- forecasted
- Posted
- Sep 23, 2025
- Funding instrument
- Cooperative Agreement
- Category
- Health
- Cost sharing required
- No
Who can apply
- •City or township governments
- •Public housing authorities/Indian housing authorities
- •County governments
- •Others (see text field entitled "Additional Information on Eligibility" for clarification)
- •Public and State controlled institutions of higher education
- •Small businesses
- •For profit organizations other than small businesses
- •Independent school districts
- •Native American tribal governments (Federally recognized)
- •Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- •Special district governments
- •Native American tribal organizations (other than Federally recognized tribal governments)
- •Private institutions of higher education
- •State governments
- •Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Contact
Brian Klein, PhD · brian.klein@nih.gov